Literature DB >> 19370691

Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines for adults with obstructive sleep apnoea.

Ian Smith1, Vidya Nadig, Toby J Lasserson.   

Abstract

BACKGROUND: Although effective in the treatment of obstructive sleep apnoea (OSA), continuous positive airway pressure (CPAP) does not meet with universal acceptance by users. Educational, supportive and behavioural interventions may help people with obstructive sleep apnoea recognise the need for regular and continued use of continuous positive airway pressure.
OBJECTIVES: To critically assess strategies that are educational, or supportive, or behavioural in encouraging people who have been prescribed or offered CPAP to use their machines. SEARCH STRATEGY: Searches were conducted on the Cochrane Airways Group Sleep Apnoea trials register. Searches are current to September 2008. SELECTION CRITERIA: Randomised parallel group studies which assessed an intervention aimed to inform participants about CPAP or OSA, or to support them in using CPAP or to modify their behaviour in increasing their use of CPAP machines. Studies of any duration were considered. DATA COLLECTION AND ANALYSIS: Two authors assessed studies to determine their suitability for inclusion in the review. Data were extracted independently and entered in to Review Manager software. MAIN
RESULTS: Seventeen studies met the review entry criteria (1070 participants). Support/encouragement offered on an ongoing basis led to increased average machine usage (0.59 hours/night (95% CI 0.26 to 0.92), although there was a significant degree of variation between the results of the studies. The effects of these interventions on the likelihood of study withdrawal, symptoms and quality of life were not statistically significant.Short-course educational intervention was not more successful in improving average machine usage than usual care.Cognitive behavioural therapy led to a significant improvement in average machine usage in two studies (2.92 hours/night (95% CI 1.93 to 3.92)), and a number needed to treat of 3 (95% CI 2 to 6) for one additional patient to achieve machine usage of six or more hours per night. Overall, In the control groups 85 people out of 100 had failed to comply with CPAP over 4 to 12 weeks, compared to 46 (95% CI 68 to 25) out of 100 for the cognitive behaviour groups. AUTHORS'
CONCLUSIONS: There is some evidence that a supportive intervention which encourages people to continue to use their CPAP machines leads to greater levels of CPAP machine usage than control, although the variation across the studies introduces some uncertainty over how consistent this effect is. We could not find evidence that a short-term educational intervention led to improvements in usage. Cognitive behavioural therapy led to the largest increases in average machine usage, partly because more participants were prepared to try out the treatment. Studies generally recruited CPAP naive patients whose sleep apnoea was severe. Trials in patients who have struggled to persist with treatment are required, as there is currently little evidence in this population. This could make a valuable contribution to our understanding of the complex relationship between initial motivation, ongoing perception of benefit and long-term health benefits.

Entities:  

Mesh:

Year:  2009        PMID: 19370691     DOI: 10.1002/14651858.CD007736

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  29 in total

1.  Toward a multi-level approach to CPAP adherence.

Authors:  Alec B Platt; Nirav P Patel
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

2.  Adherence to continuous positive airway pressure therapy in obstructive sleep apnea syndrome: effect of visual education.

Authors:  Ozen K Basoglu; Meltem Midilli; Rasit Midilli; Cem Bilgen
Journal:  Sleep Breath       Date:  2011-12-14       Impact factor: 2.816

3.  Comparison of adjustable and fixed oral appliances for the treatment of obstructive sleep apnea.

Authors:  Christopher J Lettieri; Nathalie Paolino; Arn H Eliasson; Anita A Shah; Aaron B Holley
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

4.  Adherence to APAP in obstructive sleep apnea syndrome: effectiveness of a motivational intervention.

Authors:  Ana Patrícia Teles Dantas; João Carlos Winck; Margarida Figueiredo-Braga
Journal:  Sleep Breath       Date:  2014-07-03       Impact factor: 2.816

5.  First impressions matter: transforming CPAP from efficacious to effective therapy for OSA.

Authors:  Martha E Billings; Vishesh K Kapur
Journal:  J Clin Sleep Med       Date:  2013-03-15       Impact factor: 4.062

6.  Effect of uvulopalatopharyngoplasty on CPAP compliance.

Authors:  Sang Duk Hong; Hyo Yeol Kim; Hyun-Jin Cho; Min-Seok Jang; Hun-Jong Dhong; Seung-Kyu Chung
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-10       Impact factor: 2.503

7.  Effect of addition of chin strap on PAP compliance, nightly duration of use, and other factors.

Authors:  Shelley R Knowles; Daniel T O'Brien; Shiling Zhang; Anupama Devara; James A Rowley
Journal:  J Clin Sleep Med       Date:  2014-04-15       Impact factor: 4.062

Review 8.  Comorbid insomnia in sleep-related breathing disorders: an under-recognized association.

Authors:  Suhaila E Al-Jawder; Ahmed S Bahammam
Journal:  Sleep Breath       Date:  2011-03-29       Impact factor: 2.816

9.  Adherence to Positive Airway Therapy After Switching From CPAP to ASV: A Big Data Analysis.

Authors:  Jean-Louis Pépin; Holger Woehrle; Dongquan Liu; Shiyun Shao; Jeff P Armitstead; Peter A Cistulli; Adam V Benjafield; Atul Malhotra
Journal:  J Clin Sleep Med       Date:  2018-01-15       Impact factor: 4.062

10.  A cost-effectiveness analysis of nasal surgery to increase continuous positive airway pressure adherence in sleep apnea patients with nasal obstruction.

Authors:  Judith S Kempfle; Nicholas Y BuSaba; John M Dobrowski; Michael B Westover; Matt T Bianchi
Journal:  Laryngoscope       Date:  2016-09-22       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.